
Focus on global health
At $46 billion each year – almost a quarter of all grantmaking – philanthropy spends more on health-related causes than anything else. As the Covid-19 pandemic intensifies, philanthropy has provided critical funding for vaccine development, medical equipment, mutual aid, social welfare, and global health infrastructure.
But there is intense debate about how the largest foundations interact with governments, international bodies and pharmaceutical companies and who should hold them accountable. Alliance considers new directions for global health philanthropy and explores whether health funding is going where its most needed, and asks who gets to decide.
News, analysis, interviews and more on global health philanthropy
Global health philanthropy: is it too much or not enough?

A call for coordination: philanthropy’s response to Covid-19, HIV, and sy…
How to fund health advocacy
Social enterprise success eases the healthcare gap
The downside of donor funding

New report outlines need for investment in menstrual health and hygiene

Philanthropy must invest in tackling non-communicable diseases

Inequality and infections: philanthropy must be a catalyst for changing pow…

New report explores community philanthropy’s response to Covid-19 in Lati…

Reaching youth with sexual health information in rural Zambia demands innov…

Alliance webinar: Global health philanthropy – is it too much, or not eno…

WHO Foundation appoints Anil Soni first CEO

Open Society Foundations urge reset of global health funding

Funding when disaster strikes

Register for our webinar on global health philanthropy – 10 Dec., 3pm GMT

Dr Tedros: There is great potential and need for philanthropy to partner wi…

Funding for global health: too much and not enough

In profile: Global health philanthropy

Reader survey: Philanthropy’s response to Covid-19

Alliance exclusive: Interview with Dr Tedros of the WHO

Applying the lessons of Ebola to Covid
